Navigating the diagnostic delay: optimizing timely biopsy and integrating NIR-based technologies for head and neck...

Lee et al.'s study critically explores the detrimental effects of diagnostic delays in head and neck cancer (HNC), focusing on patients who initially present through emergency departments (ED). The findings reveal that delayed biopsies, especially those performed more than 34 days after initial imaging, are associated with worse survival outcomes, highlighting the need for timely tissue diagnosis. Notably, the study identifies a 34-day threshold for biopsy completion that should guide clinical practice to improve patient prognosis. This commentary expands on the study's findings, emphasizing the importance of optimizing care coordination to minimize time from imaging to biopsy. Moreover, the integration of innovative diagnostic and theranostic technologies, particularly near-infrared (NIR) organic small molecules, presents a promising solution to expedite cancer diagnosis and treatment. NIR fluorophores, with their ability to penetrate deep tissues and provide real-time imaging, could significantly enhance the early detection and management of HNC, thereby reducing diagnostic delays and improving patient survival rates.